August 6th, 2019

HemoShear Therapeutics to Present at Wedbush PacGrow Healthcare Conference

Read More »
June 19th, 2019

HemoShear Therapeutics Names Biopharma Veteran Kathleen M. Metters, PhD, to Board of Directors

Read More »
April 17th, 2019

Q&A on HemoShear’s 3D model of the tumor microenvironment

Read more at DDN News
March 20th, 2019

Takeda and HemoShear Therapeutics Extend Exclusive Drug Discovery Partnership in Liver Diseases

Read More »
March 6th, 2019

HemoShear Therapeutics Physiological Human Tumor Model Published in Lab on a Chip Journal

Read More »
January 3rd, 2019

Horizon Pharma Plc and HemoShear Therapeutics Enter Into Exclusive Drug Discovery Collaboration in Gout

Read More »
December 4th, 2018

Carnot Biosciences, A Spin Off Of Smartzyme Biopharma, And Hemoshear Therapeutics Partner To Develope Protein-Based Therapeutics For Rare Metabolic Diseases

Read More »
November 9th, 2018

Shear Insights: HemoShear Identifies Novel Targets for Treating Liver Diseases

Read More »
September 6th, 2018

Shear Insights: HemoShear Invited to Share Expertise at 3D Modeling Conference

Read More »
July 19th, 2018

Shear Insights: HemoShear Therapeutics Continues to Engage with Rare Disease Groups

Read More »
May 24th, 2018

HemoShear technology utilized to create 3D model of cancer tumors

View on Cavalier Daily
May 7th, 2018

Pioneering New 3D Cancer Model to Speed New Treatments

View on UVA Health Newsroom
View More +


501 Locust Avenue
Suite 301
Charlottesville, Virginia 22902